Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Mineralys Therapeutics, Inc. - Common Stock
(NQ:
MLYS
)
30.17
-0.25 (-0.82%)
Streaming Delayed Price
Updated: 2:48 PM EDT, Apr 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
851,748
Open
30.35
Bid (Size)
30.12 (100)
Ask (Size)
30.19 (100)
Prev. Close
30.42
Today's Range
30.10 - 31.48
52wk Range
12.59 - 47.65
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Mineralys Therapeutics' CEO Sold Shares Worth $1.97 Million. Should Investors Avoid the Stock?
↗
April 07, 2026
This clinical-stage biotech focused on hypertension therapies reported a notable insider sale, according to new SEC filings.
Via
The Motley Fool
Topics
Regulatory Compliance
Cancer Drug Maker With $172 Million Revenue and Multiple Approved Therapies Draws $6.5 Million Investment
↗
March 13, 2026
This clinical-stage biotech develops oncology therapeutics and partners with leading institutions in cancer and immunology research.
Via
The Motley Fool
Topics
Regulatory Compliance
Performance
YTD
-15.5%
-15.5%
1 Month
+17.3%
+17.3%
3 Month
-9.7%
-9.7%
6 Month
-30.4%
-30.4%
1 Year
+117.4%
+117.4%
More News
Read More
Biotech Stock Up 365% as This $8 Million Investment Targets a Drug With 3 NDA Filings Planned
↗
March 13, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Mineralys Therapeutics Inc (NASDAQ:MLYS) Reports Q4 2025 EPS Beat and Key FDA NDA Acceptance for Lorundrostat
↗
March 12, 2026
Via
Chartmill
Earnings Scheduled For November 10, 2025
↗
November 10, 2025
Via
Benzinga
Mineralys (MLYS) Q4 2025 Earnings Call Transcript
↗
March 12, 2026
Via
The Motley Fool
Topics
Earnings
Fund Discloses Increased Mineralys Bet Amid 200% Stock Run as New Drug Application Nears
↗
December 23, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
This Fund Leaned Into 2025's Big Biotech Rally with a $9.5 Million Bet on Mineralys
↗
November 27, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
MINERALYS THERAPEUTICS INC (NASDAQ:MLYS) Beats Q3 2025 EPS Estimates and Advances Key Drug Candidate
↗
November 10, 2025
Via
Chartmill
Uncovering Potential: Mineralys Therapeutics's Earnings Preview
↗
November 07, 2025
Via
Benzinga
These 2 Healthcare Stocks Are Up Over 100% in a Month. Can They Keep Climbing?
↗
September 21, 2025
Via
The Motley Fool
It's a Small World: 3 Stocks Leading the Sudden Rebound in Small Caps
↗
September 16, 2025
Via
The Motley Fool
Topics
Economy
Stocks
These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts
↗
September 07, 2025
Via
The Motley Fool
Bruker, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
↗
September 03, 2025
Via
Benzinga
Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
↗
September 03, 2025
Via
Benzinga
Here are the top movers in Tuesday's session.
↗
September 02, 2025
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
September 02, 2025
Via
Benzinga
Top movers analysis in the middle of the day on 2025-09-02: top gainers and losers in today's session.
↗
September 02, 2025
Via
Chartmill
Air Lease, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
↗
September 02, 2025
Via
Benzinga
There are notable gap-ups and gap-downs in today's session.
↗
September 02, 2025
Via
Chartmill
Nasdaq Down 1%; Signet Jewelers Earnings Top Views
↗
September 02, 2025
Via
Benzinga
Tuesday's pre-market session: top gainers and losers
↗
September 02, 2025
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
September 02, 2025
Via
Benzinga
Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket
↗
September 02, 2025
Via
Benzinga
AstraZeneca's $80 Billion Ambition Just Got A Big Infusion With New Hypertension Results
↗
August 30, 2025
Via
Investor's Business Daily
Frequently Asked Questions
Is Mineralys Therapeutics, Inc. - Common Stock publicly traded?
Yes, Mineralys Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Mineralys Therapeutics, Inc. - Common Stock trade on?
Mineralys Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Mineralys Therapeutics, Inc. - Common Stock?
The ticker symbol for Mineralys Therapeutics, Inc. - Common Stock is MLYS on the Nasdaq Stock Market
What is the current price of Mineralys Therapeutics, Inc. - Common Stock?
The current price of Mineralys Therapeutics, Inc. - Common Stock is 30.17
When was Mineralys Therapeutics, Inc. - Common Stock last traded?
The last trade of Mineralys Therapeutics, Inc. - Common Stock was at 04/16/26 02:48 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
